Agarwal Sunil

Agarwal Sunil is listed in filings as Director at Astria Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 23, 2026, including 5 public disclosures. Recent filings connect the profile to Astria Therapeutics, Inc. (ATXS) and Arvinas, Inc. (ARVN). The current snapshot covers public activity from Jun 12, 2025 to Jan 23, 2026. Reported amounts are shown as $321.5K to $180.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.